लोड हो रहा है...
SA-4-1BBL as a Novel Adjuvant for the Development of Therapeutic Cancer Vaccines
Tumor associated antigen (TAA)-based therapeutic vaccines have great potential as a safe, practical, and cost-efficient alternative to standard treatments for cancer. Clinical efficacy of TAA-based vaccines, however, has yet to be realized and will require adjuvants with pleiotropic functions on imm...
में बचाया:
| में प्रकाशित: | Expert Rev Vaccines |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4721633/ https://ncbi.nlm.nih.gov/pubmed/24521311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2014.880340 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|